Abstract
The cannabinoid CB1 and CB2 receptors are Class A G protein-coupled receptors (GPCRs). While many Class A GPCRs have endogenous ligands that are hydrophilic cations (e.g., the serotonin and dopamine receptors), the cannabinoid receptors have neutral, highly lipophilic ligands derived from the fatty acid, arachidonic acid. The most well-studied of these are N-arachidonoylethanolamine (anandamide, AEA) and sn-2-arachidonoylglycerol (2-AG). This review focuses on the experimental and computational studies that have been used to probe the nature of endocannabinoid interaction with the cannabinoid receptors. These studies include mutation, SAR and NMR studies, as well as, QSAR, docking and molecular dynamics simulations. Gaps in our knowledge are identified. The review begins more generally, however, by discussing the entire endocannabinoid system, of which the cannabinoid receptors are part. For in order to understand endocannabinoid action, one needs an appreciation for the environments for which these ligands have been designed and the conformational changes these ligands must undergo in order to act on the cannabinoid receptors.
Keywords: Cannabinoid, GPCR, endocannabinoid, anandamide, 2-AG, molecular dynamics, QSAR, mutation
Current Medicinal Chemistry
Title: Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Volume: 17 Issue: 14
Author(s): Patricia H. Reggio
Affiliation:
Keywords: Cannabinoid, GPCR, endocannabinoid, anandamide, 2-AG, molecular dynamics, QSAR, mutation
Abstract: The cannabinoid CB1 and CB2 receptors are Class A G protein-coupled receptors (GPCRs). While many Class A GPCRs have endogenous ligands that are hydrophilic cations (e.g., the serotonin and dopamine receptors), the cannabinoid receptors have neutral, highly lipophilic ligands derived from the fatty acid, arachidonic acid. The most well-studied of these are N-arachidonoylethanolamine (anandamide, AEA) and sn-2-arachidonoylglycerol (2-AG). This review focuses on the experimental and computational studies that have been used to probe the nature of endocannabinoid interaction with the cannabinoid receptors. These studies include mutation, SAR and NMR studies, as well as, QSAR, docking and molecular dynamics simulations. Gaps in our knowledge are identified. The review begins more generally, however, by discussing the entire endocannabinoid system, of which the cannabinoid receptors are part. For in order to understand endocannabinoid action, one needs an appreciation for the environments for which these ligands have been designed and the conformational changes these ligands must undergo in order to act on the cannabinoid receptors.
Export Options
About this article
Cite this article as:
Reggio H. Patricia, Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown, Current Medicinal Chemistry 2010; 17 (14) . https://dx.doi.org/10.2174/092986710790980005
DOI https://dx.doi.org/10.2174/092986710790980005 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Refined Framework for Precision and Translational Proteomics in Clinical Research
Current Proteomics A Survey on Synthesis Processes of Structured Materials for Biomedical Applications: Iron-based Magnetic Nanoparticles, Polymeric Materials and Polymerization Processes
Current Pharmaceutical Design Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations
Current Medicinal Chemistry Medicinal Properties of Mangiferin, Structural Features, Derivative Synthesis, Pharmacokinetics and Biological Activities
Mini-Reviews in Medicinal Chemistry Thromboembolic Complications in Malignant Haematological Disorders
Current Vascular Pharmacology Recent Advances in the Discovery of Antiviral Metabolites from Fungi
Current Pharmaceutical Biotechnology Diversity in Antibacterial Activity of Thiosemicarbazides Derived from 3-Chlorobenzhydrazide
Letters in Drug Design & Discovery When Less Means More: Impact of Myostatin in Animal Breeding
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Impact of COVID-19 on Indian Pharmaceutical Industry and Way Forward
Infectious Disorders - Drug Targets Recent Patents Therapeutic Agents for Cancer
Recent Patents on Anti-Cancer Drug Discovery Sleep Quality and Quality of Life Among Older Adults During COVID-19 Pandemic: A Cross-Sectional Study
Current Aging Science Cannabinoid Receptors as Therapeutic Targets
Current Pharmaceutical Design Novel Hybrid Molecules of Quinazoline Chalcone Derivatives: Synthesis and Study of in vitro Cytotoxic Activities
Letters in Drug Design & Discovery Antimicrobial Activity of Diazenyl Derivatives: An Update
Current Topics in Medicinal Chemistry Progress in Cationic Lipid-Mediated Gene Transfection: A Series of Bio- Inspired Lipids as an Example
Current Gene Therapy Synthesis of Substituted N-aryl-N-Sulfamoyloxazolidin-2-ones with Potential Antibacterial Activity
Recent Patents on Anti-Infective Drug Discovery Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Letters in Drug Design & Discovery Targeting DNA Minor Groove by Hybrid Molecules as Anticancer Agents
Current Medicinal Chemistry RING Finger E3 Ubiquitin Ligases: Structure and Drug Discovery
Current Pharmaceutical Design Methemoglobinaemia in Diabetic Ketoacidosis Patient
New Emirates Medical Journal